Clinical Trial Update: Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing dalteparin with unfractionated heparin for the prevention of venous thromboembolism in hospitalized acutely ill medical patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dalteparin (Fragmin) (dalteparin sodium)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Pfizer | Conditions: Venous Thromboembolism | Phase 4 | Status: TERMINATED | Results posted: 2009-10-02